In preclinical analyses evaluating potential factors contributing to tumor growth in VHL-null Drosophila and human clear cell RCC, synthetic lethality was discovered between VHL and the cell cycle regulators cyclin-dependent kinases 4 and 6 (CDK4/6) [56]. The gene discussed is VHL; the disease is neoplasm.